Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 106, Issue -, Pages 367-380Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2016.06.006
Keywords
Pharmacokinetics and pharmacodynamics of peptide and protein drugs; Nanoparticles for oral administration; Bioavailability; Regulatory challenges; Physiologically-based pharmacokinetic modelling
Categories
Funding
- European Union [281035]
Ask authors/readers for more resources
The influence of nanoparticle (NP) formulations on the pharmacokinetic, pharmacodynamic and biodistribution profiles of peptide- and protein-like drugs following oral administration is critically reviewed. The possible mechanisms of absorption enhancement and the effects of the physicochemical properties of the NP are examined. The potential advantages and challenges of physiologically-based pharmacokinetic (PBPK) modelling to help predict efficacy in man are discussed. The importance of developing and expanding the regulatory framework to help translate the technology into the clinic and accelerate the availability of oral nanoparticulate formulations is emphasized. In conclusion, opportunities for future work to improve the state of the art of oral nanomedicines are identified. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available